Cargando…
The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304026/ http://dx.doi.org/10.1186/1710-1492-10-S2-A17 |
| _version_ | 1782354020350820352 |
|---|---|
| author | Maloney, Jennifer Bernstein, David I Hébert, Jacques White, Martha Fisher, Robert Casale, Thomas B Kaur, Amarjot Nolte, Hendrik |
| author_facet | Maloney, Jennifer Bernstein, David I Hébert, Jacques White, Martha Fisher, Robert Casale, Thomas B Kaur, Amarjot Nolte, Hendrik |
| author_sort | Maloney, Jennifer |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4304026 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43040262015-02-12 The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis Maloney, Jennifer Bernstein, David I Hébert, Jacques White, Martha Fisher, Robert Casale, Thomas B Kaur, Amarjot Nolte, Hendrik Allergy Asthma Clin Immunol Meeting Abstract BioMed Central 2014-12-18 /pmc/articles/PMC4304026/ http://dx.doi.org/10.1186/1710-1492-10-S2-A17 Text en Copyright © 2014 Maloney et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Abstract Maloney, Jennifer Bernstein, David I Hébert, Jacques White, Martha Fisher, Robert Casale, Thomas B Kaur, Amarjot Nolte, Hendrik The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| title | The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| title_full | The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| title_fullStr | The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| title_full_unstemmed | The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| title_short | The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| title_sort | efficacy and safety of the short ragweed sublingual immunotherapy tablet mk-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304026/ http://dx.doi.org/10.1186/1710-1492-10-S2-A17 |
| work_keys_str_mv | AT maloneyjennifer theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT bernsteindavidi theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT hebertjacques theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT whitemartha theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT fisherrobert theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT casalethomasb theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT kauramarjot theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT noltehendrik theefficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT maloneyjennifer efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT bernsteindavidi efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT hebertjacques efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT whitemartha efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT fisherrobert efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT casalethomasb efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT kauramarjot efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis AT noltehendrik efficacyandsafetyoftheshortragweedsublingualimmunotherapytabletmk3641issimilarinasthmaticandnonasthmaticsubjectstreatedforallergicrhinitiswithwithoutconjunctivitis |